Page last updated: 2024-08-26

nicotine and (3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid

nicotine has been researched along with (3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Banerjee, D; Finn, MG; Froestl, W; Guery, S; Kaupmann, K; Markou, A; Paterson, NE; Vlachou, S	1

Other Studies

1 other study(ies) available for nicotine and (3-(1-((3-(cyclohexylmethyl)hydroxyphosphinyl)-2-hydroxypropyl)amino)ethyl)benzoic acid

Article	Year
Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats. European journal of pharmacology, 2011, Mar-25, Volume: 655, Issue:1-3 Topics: Animals; Benzoates; Depression; Drug Synergism; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Male; Nicotine; Phosphinic Acids; Pyrimidines; Rats; Rats, Wistar; Receptors, GABA-B; Reward; Self Stimulation; Substance Withdrawal Syndrome	2011

Article

Year

Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats.

European journal of pharmacology, 2011, Mar-25, Volume: 655, Issue:1-3

Topics: Animals; Benzoates; Depression; Drug Synergism; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; gamma-Aminobutyric Acid; Male; Nicotine; Phosphinic Acids; Pyrimidines; Rats; Rats, Wistar; Receptors, GABA-B; Reward; Self Stimulation; Substance Withdrawal Syndrome

2011